Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 8/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MBTD1 | Q05BQ5 | 5/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.36 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27218548 | 0.98 | L3MBTL3 (0.41) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| Hydrochloric Acid SCHEMBL27218545 | 0.98 | L3MBTL3 (0.41) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL19312856 | 0.93 | L3MBTL3 (0.46) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL26630547 | 0.89 | L3MBTL3 (0.41) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL22688665 | 0.86 | L3MBTL3 (0.42) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL2227575 | 0.82 | KDM4E (0.41) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL14838336 | 0.82 | KDM4E (0.41) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL28902671 | 0.80 | KDM4E (0.36) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| SCHEMBL30909113 | 0.80 | L3MBTL3 (0.36) | L3MBTL3L3MBTL1KDM4ETDP1MBTD1 | |
| Ammonia Solution, Strong SCHEMBL7193166 | 0.80 | HTR6 (0.52) | L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015932-A1 | BIOORTHOGONAL COMPOSITIONS | TAMBO, INC. | 2021-01-21 | — | — | US | disclosed |
| US-10828373-B2 | Bioorthogonal compositions | TAMBO, INC. (US) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10828373-B2 | Bioorthogonal compositions | CD47, EPHA2, MSN | L3MBTL3 227/4885L3MBTL1 482/4885KDM4E 3801/4885 |
| US-20210015932-A1 | BIOORTHOGONAL COMPOSITIONS | CD47, EPHA2, MSN | L3MBTL3 227/4885L3MBTL1 482/4885KDM4E 3801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.